Hi All,
I was hoping someone in Biotech ER/VC/IB could share a model they used to forecast the IS for a pre-revenue company. Preferably one where there is a revenue build with # of patients, prevalence, adoption curve etc. included. This would be a massive help. Thanks in advance.
| +273 | Earliest you can get fired | 58 | 1d |
| +251 | Investment Banking is Divine | 40 | 1d |
| +214 | Another $115bn Mega deal for these banks. Congrats! | 45 | 1d |
| +213 | US 2027 SA IB worried about background check | 53 | 23h |
| +206 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 41 | 1d |
| +131 | Is UBS really that bad? | 38 | 1d |
| +40 | Is Houston SA 28 recruiting already over? | 34 | 11h |
| +27 | FIG Pigeonholes you - is it true? | 8 | 1d |
| +27 | 2026-27 IB Energy Top Banks | 8 | 1d |
| +24 | How do you manage nerves in IB technical interviews? | 6 | 5h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
bump
Pull an equity research report and copy their build.
SGMO, QURE, ONCE, GBT all have similar builds to what you describe.
Et id placeat quis saepe molestiae id. Esse et ducimus ex. Et veritatis sed laudantium id. Maiores consequatur saepe quis fugit doloremque. Iusto dolores quo quod enim et sint. Mollitia doloremque sunt tenetur consequatur suscipit itaque. Eveniet porro aliquam iste.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...